Conference Description

October 28-29, 2006
Doubletree Chicago - Arlington Heights
75 West Algonquin Road
Arlington Heights, IL 60005
847-364-7600

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 10*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. more fully understand the origins of insulin resistance and type 2 Diabetes, and review studies of atherosclerosis prevention in patients with type 2 Diabetes
2. utilize appropriate first line therapies in the treatment of diabetes with the goal of targeting the various metabolic pathways in the management of hyperglycemia, thereby preventing development of complications
3. understand the role for insulin in patients with type 2 diabetes and develop strategies for initiating and adjusting therapy
4. utilize evolving data and novel therapies to understand and more effectively manage patients with chronic constipation
5. more fully understand chronic insomnia, its comorbidities, and effective treatment strategies
6. evaluate and diagnose the anemia of chronic kidney disease, understand its impact on quality of life, and guide treatment decisions based on emerging data
7. identify first line anti-hypertensive therapies, the data from which such decisions have evolved and describe the role of modulation of other cardiovascular risk markers such as microalbuminuria, and LVH in patients with hypertension
8. identify surrogates of mortality in COPD and better utilize targeted patient interventions that improve patient’s outcomes
9. recognize the signs of Pulmonary Arterial Hypertension, guide appropriate evaluation and discuss the latest therapeutic options
10. discuss the epidemiology, diagnostic evaluation, and treatment options of thyroid nodules

Agenda:
Saturday, October 28, 2006

7:30-8:10 am		Registration, Continental Breakfast and Welcome
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Insulin Resistance: From Impaired Glucose Tolerance to Type 2 Diabetes – Pathophysiologic Origins, Progression to Diabetes, Prevention of Atherosclerosis Patrick Boyle, MD
9:20-10:20		Treatment Early in the Time Course of Type 2 Diabetes Patrick Boyle, MD
10:20-10:40		Break
10:40-11:40		Beyond Oral Agents: Insulin Initiation and Management Cristina Mata, MD
11:40-12:40		Paving the Way to Relief in Chronic Constipation Brooks D. Cash, MD, FACP
12:40-1:30		Lunch
1:30-2:30		Insomnia Phyllis Zee, MD
2:30-3:30		Anemia in Chronic Kidney Disease: Clinical Implications and Treatment Options William McClellan, MD
3:30-3:50		Break
3:50-4:50		Hypertension: New Directions Lou Kuritzky, MD

Sunday, October 29, 2006

8:00-8:30 am		Continental Breakfast and Welcome
8:30-9:30		Recent Developments on COPD and its Management Nicholas Gross, MD
9:30-10:30		Pulmonary Arterial Hypertension Franck F. Rahaghi, MD, MHS, FCCP
10:30-10:50		Break
10:50-11:50		Thyroid Nodule Evaluation 2006 James Hennessey, MD
11:50-12:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico

Brooks D. Cash, MD, FACP
CDR, MC, USN
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine
National Naval Medical Center

Nicholas Gross, MD
Professor of Medicine at Stritch-Loyola School
of Medicine in Chicago
Member of the Attending Staff at Hines VA Hospital

James V. Hennessey, MD
Associate Professor of Medicine
Division of Endocrinology
Brown Medical School

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainseville, FL

Cristina Mata, MD
Medical Director of Diabetes Services
Holy Cross Hospital
Fort Lauderdale, FL

William McClellan, Jr., MD, MPH
Professor, Department of Medicine, Division of Renal Medicine
Emory University School of Medicine

Franck F. Rahaghi, MD, MHS, FCCP
Director, Pulmonary Hypertension Clinic
Pulmonary and Critical Care
Cleveland Clinic Florida at Weston

Phyllis C. Zee, MD, PhD
Professor of Neurology and Neurobiology & Physiology
Northwestern University
Chicago, Il

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 10 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 10 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 12 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Abbott, Actelion, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.